In a significant step towards improving the quality of life for children with advanced cancer, a study led by Mass General Brigham has demonstrated the potential benefits of personalized palliative care. The research, published in the Journal of Clinical Oncology, explored whether systematic feedback on symptoms and quality of life, followed by tailored palliative interventions, could enhance patient experiences.
The study’s findings suggest that integrating routine electronic feedback with specialized pediatric palliative care (SPPC) can ease suffering and improve well-being among young cancer patients. “We show that integrating routine electronic feedback with palliative care has the potential to ease suffering and enhance well-being in pediatric cancer patients,” stated Dr. Veronica Dussel, the study’s first author and an associate research scientist in the Department of Pediatrics at Mass General Brigham for Children.
The Need for Specialized Pediatric Palliative Care
Specialized palliative care aims to alleviate symptoms that are often perceived as a normal part of cancer, such as pain, nausea, or fatigue. While this approach is a standard component of care for adults with advanced cancer, its use in pediatric cases remains inconsistent. The study aimed to address this gap by evaluating the impact of SPPC on children’s quality of life through a randomized controlled trial.
The trial, known as PediQUEST Response, involved 154 children aged two and older with advanced cancer, recruited from five pediatric cancer facilities across the United States. Participants were divided into two groups: one received standard care, while the other received additional palliative support, including personalized recommendations based on electronically reported symptoms.
Study Findings and Implications
After 16 weeks, both patients and parents in the intervention group reported improvements in quality of life compared to their baseline, whereas the control group noted smaller gains. “Electronic tools can help patients more comfortably report on their symptoms and quality of life, and our results show that electronic surveys are most powerful when they trigger action, not just monitoring,” explained Dr. Joanne Wolfe, senior author and physician-in-chief at Mass General Brigham for Children.
However, the improvements in the SPPC group did not exceed the “minimally clinically important difference,” suggesting the need for further research with larger sample sizes to confirm these results.
The researchers noted that variations in cancer types and inconsistencies in trial execution across clinical centers might have influenced the outcomes. “Our results show that integrating early palliative care is promising, but requires consistent delivery to be effective,” added Wolfe. “Study sites with better adherence to the palliative care protocol saw more clinically meaningful benefits, showing that implementation matters.”
Looking Ahead: The Future of Pediatric Palliative Care
The study underscores the importance of consistent and early integration of palliative care in pediatric oncology. As the healthcare community continues to explore ways to enhance the quality of life for young patients, the findings from this research offer a promising direction.
Authorship of the study includes contributions from Mass General Brigham researchers Madeline Avery, Liliana Orellana, Maria L. Requena, Denise Becker, Christina K. Ullrich, Chris Feudtner, Jason L. Freedman, Tammy I. Kang, Elisha D. Waldman, Cynthia A. Gerhardt, Marie A. Bakitas, Justin N. Baker, Stefan J. Friedrichsdorf, and Abby R. Rosenberg.
The study was funded by the National Institutes of Health National Institute of Nursing Research under R01 grant No. 5 R01 NR016720-03. For further details, the paper is cited as Dussel, V et al. “Integrating Electronic Patient-Reported Outcomes and Palliative Care in Pediatric Advanced Cancer: The PediQUEST Response Multisite Randomized Controlled Trial” in the Journal of Clinical Oncology.
